1. Home
  2. Presentation
  3. CiPA Validation of hiPSC-derived Cardiomyocytes

CiPA Validation of hiPSC-derived Cardiomyocytes

When you need a reproducible, CiPA-validated, in vitro model for cardiotoxicity screening that’s ready in under a week, you need these human iPSC derived cardiomyocytes.

Check out the data from testing Axol Bisocience’s ventricular cardiomyocytes with the 28 CiPA compounds using Voltage Sensitive Dyes (VSD).